Moleculin Biotech, Inc. (MBRX) Stock Price & Analysis
Moleculin Biotech, Inc. (MBRX) rose 5.09% to USD 0.71 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
MBRX last closed at USD 0.71; the session ranged USD 0.68–0.74 on volume of 775,601 shares. Market capitalization is —, with a 52-week range of USD 0.16–15.75 (NCM). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 0.71 |
|---|---|
| Change | ▲ 5.09% (up) |
| Previous Close | USD 0.71 |
| Open | USD 0.71 |
| Day Range | USD 0.68 – 0.74 |
| 52-Week Range | USD 0.16 – 15.75 |
| Volume | 775,601 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (MBRX)
Nexqual's technical model rates MBRX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.9 (neutral) |
| vs SMA50 | Below (USD 1.39) |
| MACD | -0.16 (negative) |
From Moleculin Biotech, Inc.'s Latest SEC 10-K Filing (filed 2026-03-18)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CAPR | Capricor Therapeutics, Inc. | USD 9.4 | ▼ 4.95% |
| PULM | Pulmatrix, Inc. | USD 1.39 | ▼ 5.44% |
| CFOR | CapForce Inc. | USD 5.15 | ▲ 0% |
| AYTU | Aytu BioPharma, Inc. | USD 2.21 | ▼ 3.07% |
| SNGX | Soligenix, Inc. | USD 0.38 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.